PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,683.00
Bid: 3,682.00
Ask: 3,684.00
Change: -64.00 (-1.71%)
Spread: 2.00 (0.054%)
Open: 3,742.00
High: 3,755.00
Low: 3,682.00
Prev. Close: 3,747.00
EXPN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Experian to acquire Illion in ANZ

4 Apr 2024 18:00

RNS Number : 4039J
Experian plc
04 April 2024
 

 

news release

 

 

EXPERIAN TO ACQUIRE ILLION IN AUSTRALIA AND NEW ZEALAND

 

4 April 2024 - Experian, the global information services company, is pleased to announce that it has signed an agreement to acquire illion, one of the leading consumer and commercial credit bureaus in Australia and New Zealand.

 

Brian Cassin, Chief Executive Officer said:

"We are delighted to announce that Experian has entered into an agreement to acquire illion, a highly complementary business to Experian in Australia and New Zealand (A/NZ), which will enhance the competitive dynamics in this important market. This marks a pivotal step in our longstanding commitment to the region and reinforces our dedication to delivering exceptional value and more choice to clients in A/NZ."

 

Overview and Strategic Rationale

Established in 1986 in Australia, illion is a bureau provider of consumer credit reporting, commercial credit reporting, and identity and verification solutions in Australia and New Zealand.

 

Our strategy in EMEA and Asia Pacific is to focus on markets where we have a clear opportunity to operate at scale and deliver innovation-led growth. Experian has successfully operated in A/NZ for over 30 years, serving lending and other institutions with decisioning software, open data and data quality services, as well as consumer bureau services. Australia is currently Experian's fifth largest country of operation by revenue.

 

The Australian lending market, like many of our developed markets, is on a journey to help widen access to credit, lower lending costs and improve digital banking services for consumers and businesses. A series of regulatory reforms in Australia have introduced comprehensive (positive) data and open data services and have widened the array of data assets, scores and analytical insights being adopted by banks and other institutions. This has enhanced appetite for analytical tools and data-driven services, expanding our addressable market opportunity.

 

The acquisition of illion will enable Experian to make full use of this opportunity and offer enhanced choice in A/NZ by providing a meaningful competitive alternative to help businesses accelerate the adoption of digital services. It is highly complementary and synergistic to Experian A/NZ, the combination of which would present a more complete service for clients, adding depth in consumer bureau services, an attractive position in commercial credit bureau services as well as capabilities in identity management solutions. This compares to Experian's strengths in analytical product capability, decisioning software and certain open banking solutions.

 

More businesses in A/NZ will benefit from Experian's leading global platforms to speed up the process of credit granting, enhance digital experiences for users, reduce fraudulent exposure and improve efficiency in banking and other sectors. Experian will be well positioned to introduce more innovation in Australia through capabilities such as the Experian Ascend unified platform, which encompasses Experian's sophisticated analytics, and our PowerCurve decisioning suite.

 

Financial information

The acquisition of 100% of illion is for a total consideration of up to A$820m (c.US$532m*), payable on completion of the transaction and to be funded from Experian's existing cash resources. The acquisition is subject to regulatory review by the competition authority in Australia which we anticipate will conclude in the second half of calendar year 2024. In the first full year of ownership we expect the acquisition to add revenues of c. A$175m and Benchmark EBITDA of c. A$65m. This compares to Experian revenues in A/NZ which are expected to be c. A$115m in FY24.

 

* AUS$/US$ spot exchange rate of 1.54 as at 3 April 2024 

 

Contact:

Experian

Nadia Ridout-Jamieson Investor queries +44 (0)20 3042 4220

Gerry Tschopp, Nick Jones Media queries

 

Teneo

Graeme Wilson and Louise Male +44 (0)20 7353 4200

 

 

 

About Experian

Experian is the world's leading global information services company. During life's big moments - from buying a home or a car, to sending a child to college, to growing a business by connecting with new customers - we empower consumers and our clients to manage their data with confidence. We help individuals to take financial control and access financial services, businesses to make smarter decisions and thrive, lenders to lend more responsibly, and organisations to prevent identity fraud and crime.

 

We have 22,400 people operating across 32 countries and every day we're investing in new technologies, talented people, and innovation to help all our clients maximise every opportunity. With corporate headquarters in Dublin, Ireland, we are listed on the London Stock Exchange (EXPN) and are a constituent of the FTSE 100 Index.

 

Learn more at www.experianplc.com or visit our global content hub at our global news blog for the latest news and insights from the Group.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQQZLFBZZLZBBK
Date   Source Headline
31st Oct 20229:30 amRNSTotal Voting Rights
14th Oct 20229:51 amRNSShare Repurchase Programme
6th Oct 20227:00 amRNSDirectorate Change
5th Oct 20229:10 amRNSAdditional Listing
30th Sep 202212:06 pmRNSTotal Voting Rights
28th Sep 20229:02 amRNSAdditional Listing
19th Sep 202210:00 amRNSBlock listing Interim Review
14th Sep 20229:30 amRNSAdditional Listing
7th Sep 20229:30 amRNSAdditional Listing
31st Aug 202210:07 amRNSTotal Voting Rights
31st Aug 20229:30 amRNSAdditional Listing
17th Aug 20229:30 amRNSAdditional Listing
10th Aug 20229:15 amRNSAdditional Listing
29th Jul 20229:57 amRNSTotal Voting Rights
28th Jul 20229:25 amRNSDirector/PDMR Shareholding
21st Jul 202211:15 amRNSResult of AGM
21st Jul 202210:30 amRNSDirector Declaration
20th Jul 20229:30 amRNSAdditional Listing
14th Jul 20227:00 amRNSTrading update, first quarter
1st Jul 20225:42 pmRNSSecond Interim Dividend
30th Jun 20225:50 pmRNSTransaction in Own Shares
30th Jun 20224:00 pmRNSDirector/PDMR Shareholding
30th Jun 202210:54 amRNSTotal Voting Rights
29th Jun 20225:12 pmRNSTransaction in Own Shares
28th Jun 20225:28 pmRNSTransaction in Own Shares
27th Jun 20225:14 pmRNSTransaction in Own Shares
27th Jun 20222:15 pmRNSHolding(s) in Company
24th Jun 20225:41 pmRNSTransaction in Own Shares
24th Jun 202210:51 amRNSDirector/PDMR Shareholding
23rd Jun 20225:19 pmRNSTransaction in Own Shares
22nd Jun 20225:50 pmRNSTransaction in Own Shares
20th Jun 20225:26 pmRNSTransaction in Own Shares
17th Jun 20225:10 pmRNSTransaction in Own Shares
16th Jun 20225:33 pmRNSTransaction in Own Shares
15th Jun 20226:29 pmRNSTransaction in Own Shares
15th Jun 20225:36 pmRNSTransaction in Own Shares
15th Jun 202210:00 amRNSDirector/PDMR Shareholding
10th Jun 20223:39 pmRNSAnnual Financial Report
10th Jun 202210:00 amRNSElections for second interim dividend
9th Jun 20224:15 pmRNSDirector/PDMR Shareholding
31st May 202211:42 amRNSTotal Voting Rights
26th May 20225:08 pmRNSTransaction in Own Shares
25th May 20225:43 pmRNSTransaction in Own Shares
24th May 20225:22 pmRNSTransaction in Own Shares
23rd May 20225:41 pmRNSTransaction in Own Shares
20th May 20225:35 pmRNSTransaction in Own Shares
19th May 20225:38 pmRNSTransaction in Own Shares
18th May 20226:15 pmRNSTransaction in Own Shares
18th May 202211:30 amRNSShare repurchases
18th May 20227:00 amRNSFull-year financial report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.